Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Carbone

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
Cancer Research|August 4, 2004
Modern criteria to establish human cancer etiologyMichele Carbone, George Klein, Jack Gruber, et al.
Seminars in Oncology|February 12, 2002
The pathogenesis of mesotheliomaMichele Carbone, Robert A Kratzke, Joseph R Testa
Expert Review of Respiratory Medicine|September 30, 2011
Simian virus 40 transformation, malignant mesothelioma and brain tumorsFang Qi, Michele Carbone, Haining Yang, et al.
Hawaii Medical Journal|March 31, 2007
MesotheliomaMichele Carbone, Oriana Strianese, Kimberly Theos, et al.
Oncogene|January 16, 2003
Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cellsMaurizio Bocchetta, Lucio Miele, Harvey I Pass, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?Michele Carbone, Haining Yang, Harvey I Pass, et al.
Current Problems in Cancer|June 16, 2004
Malignant pleural mesotheliomaHarvey I Pass, Nicholas Vogelzang, Steven Hahn, et al.
Seminars in Diagnostic Pathology|October 19, 2006
Spindle cell tumors of the pleura: differential diagnosisMonica Rdzanek, Raoul Fresco, Harvey I Pass, et al.
Journal of Translational Medicine|October 26, 2023
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesotheliomaMichele Carbone, Michael Minaai, Yasutaka Takinishi, et al.
Future Oncology (London, England)|June 4, 2008
Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignanciesAmanda K Beck, Harvey I Pass, Michele Carbone, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Cancer Research|August 4, 2004
Modern criteria to establish human cancer etiologyMichele Carbone, George Klein, Jack Gruber, et al.
Seminars in Oncology|February 12, 2002
The pathogenesis of mesotheliomaMichele Carbone, Robert A Kratzke, Joseph R Testa
Expert Review of Respiratory Medicine|September 30, 2011
Simian virus 40 transformation, malignant mesothelioma and brain tumorsFang Qi, Michele Carbone, Haining Yang, et al.
Hawaii Medical Journal|March 31, 2007
MesotheliomaMichele Carbone, Oriana Strianese, Kimberly Theos, et al.
Oncogene|January 16, 2003
Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cellsMaurizio Bocchetta, Lucio Miele, Harvey I Pass, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?Michele Carbone, Haining Yang, Harvey I Pass, et al.
Current Problems in Cancer|June 16, 2004
Malignant pleural mesotheliomaHarvey I Pass, Nicholas Vogelzang, Steven Hahn, et al.
Seminars in Diagnostic Pathology|October 19, 2006
Spindle cell tumors of the pleura: differential diagnosisMonica Rdzanek, Raoul Fresco, Harvey I Pass, et al.
Journal of Translational Medicine|October 26, 2023
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesotheliomaMichele Carbone, Michael Minaai, Yasutaka Takinishi, et al.
Future Oncology (London, England)|June 4, 2008
Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignanciesAmanda K Beck, Harvey I Pass, Michele Carbone, et al.
Pageof 17